Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?
- PMID: 27966794
- DOI: 10.1002/jcp.25739
Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?
Abstract
Exosomes have emerged as one of the main players in intercellular communication. These small nano-sized particles have many roles in various physiological pathways in normal and abnormal cells. Exosomes can carry various cargos such as proteins, mRNAs, and miRNAs to recipient cells. Uptake of exosomes and their cargo can induce and/or inhibit different cellular and molecular pathways that lead to the alteration of cell behavior. Multiple lines of evidence have indicated that exosomes released from cancer cells can effect development of cancer in different stages. These particles and their cargo could regulate different processes such as tumor growth, metastasis, drug resistance, angiogenesis, and immune system functioning. It has been observed that exosomes can be used as potential diagnostic biomarkers in various cancer types. Moreover, some studies have used these particles as biological vehicles for delivery of various drugs such as doxorubicin, siRNAs, and miRNAs. Here, we summarized the findings on the role of exosomes in different pathological processes involved in cancer. Moreover, application of these particles as diagnostic and therapeutic biomarkers in different types of cancers is discussed. J. Cell. Physiol. 232: 3251-3260, 2017. © 2016 Wiley Periodicals, Inc.
© 2016 Wiley Periodicals, Inc.
Similar articles
-
Exosomes: Potent regulators of tumor malignancy and potential bio-tools in clinical application.Crit Rev Oncol Hematol. 2015 Sep;95(3):346-58. doi: 10.1016/j.critrevonc.2015.04.002. Epub 2015 May 5. Crit Rev Oncol Hematol. 2015. PMID: 25982702 Review.
-
The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].Cell Oncol (Dordr). 2018 Jun;41(3):223-252. doi: 10.1007/s13402-018-0378-4. Epub 2018 Apr 17. Cell Oncol (Dordr). 2018. PMID: 29667069 Review.
-
The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.Int J Mol Sci. 2019 Sep 21;20(19):4687. doi: 10.3390/ijms20194687. Int J Mol Sci. 2019. PMID: 31546654 Free PMC article. Review.
-
Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer.Mol Pharm. 2019 Aug 5;16(8):3333-3349. doi: 10.1021/acs.molpharmaceut.9b00409. Epub 2019 Jul 10. Mol Pharm. 2019. PMID: 31241965 Review.
-
Exosomes, new biomarkers in early cancer detection.Anal Biochem. 2019 Apr 15;571:1-13. doi: 10.1016/j.ab.2019.02.013. Epub 2019 Feb 15. Anal Biochem. 2019. PMID: 30776327 Review.
Cited by
-
Application of microfluidic technology based on surface-enhanced Raman scattering in cancer biomarker detection: A review.J Pharm Anal. 2023 Dec;13(12):1429-1451. doi: 10.1016/j.jpha.2023.08.009. Epub 2023 Aug 23. J Pharm Anal. 2023. PMID: 38223444 Free PMC article. Review.
-
Editorial: Molecular and cellular mechanisms for cancer therapy resistance.Front Oncol. 2023 Nov 29;13:1340318. doi: 10.3389/fonc.2023.1340318. eCollection 2023. Front Oncol. 2023. PMID: 38094612 Free PMC article. No abstract available.
-
Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy.Int J Mol Sci. 2023 May 31;24(11):9547. doi: 10.3390/ijms24119547. Int J Mol Sci. 2023. PMID: 37298496 Free PMC article. Review.
-
Exosomes as Rheumatoid Arthritis Diagnostic Biomarkers and Therapeutic Agents.Vaccines (Basel). 2023 Mar 17;11(3):687. doi: 10.3390/vaccines11030687. Vaccines (Basel). 2023. PMID: 36992270 Free PMC article. Review.
-
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines.Front Oncol. 2023 Feb 16;13:1129832. doi: 10.3389/fonc.2023.1129832. eCollection 2023. Front Oncol. 2023. PMID: 36874116 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
